Glybovin

No, Glybovin 1.25mg Tablet and Glipizide are different medicines. However, they belong to the same class of medicines called sulfonylureas and are used to treat type 2 diabetes mellitus in adults.

No, Glybovin 1.25mg Tablet is not known to have any role in the treatment of polycystic ovarian syndrome (PCOS). Also, there is no clinical evidence available regarding the same.

Glybovin 1.25mg Tablet should be used with extra caution in elderly patients because they are at high risk of getting low blood sugar (hypoglycemic event).

Glybovin 1.25mg Tablet is not used for the management of prediabetes, a condition with blood glucose levels higher than normal but not high enough to label you as diabetic. There are clinical studies available, but the evidence is not strong enough for its use in prediabetes.

Both Glybovin 1.25mg Tablet and Teneligliptin are antidiabetic medicines and control blood sugar levels effectively. However, they work in different ways and may show different kinds of side effects. Glybovin 1.25mg Tablet commonly causes hypoglycemia and weight gain while Teneligliptin causes headache and nasopharyngitis. Teneligliptin causes hypoglycemia when used along with insulins or sulfonylureas and does not cause weight gain.

No, Glybovin 1.25mg Tablet should not be skipped as it can make your diabetes worse. If you miss the dose by mistake, take it as soon as you remember.

Use of Glybovin 1.25mg Tablet should be avoided if you are allergic (hypersensitive) to sulfonylureas or sulfonamides or any of the other ingredients of this medicine.

Yes, Glybovin 1.25mg Tablet can cause weight gain. It is advisable to closely monitor your diet and exercise regularly while taking this medicine. Avoid skipping your meals as it can cause very low blood sugar levels and you may end up snacking or taking a lot of sugars.

Glybovin 1.25mg Tablet, when used with insulin, can help to control high blood sugar levels. Taking them together can help to lower the dose of insulin but there could also be an increased risk of hypoglycemia (low blood sugar levels). The dose of these medicines may need to be adjusted along with regular blood sugar level monitoring. Please consult your doctor if you have any doubts and follow your doctor's instructions carefully to get maximum benefit of Glybovin 1.25mg Tablet.

Yes, Glybovin 1.25mg Tablet and Liraglutide can be taken together, as they can help in better control of blood sugar levels. However, the risk of low blood sugar levels (hypoglycemia) can increase. Consult your doctor as a dose adjustment of the two may be needed.

No, Glybovin 1.25mg Tablet is not a Thiazolidinedione, it is a sulfonylurea. However, both are antidiabetic medicines but belong to a different group of medicines.

The use of insulin is advised during pregnancy to control the blood glucose levels. Insulin injections are the standard medication for gestational diabetes. Glybovin 1.25mg Tablet may be advised as an alternative or in addition to insulin for the management of gestational diabetes. However, do not start taking Glybovin 1.25mg Tablet until prescribed by the doctor.

No, hair loss is not seen with the use of Glybovin 1.25mg Tablet. However, diabetes can lead to hair loss. Talk to your doctor if you have excessive hair loss as it could be due to some other underlying condition or it could be a sign of your diabetes getting worsened.

Yes, it is safe to take Glybovin 1.25mg Tablet with Pioglitazone in patients with diabetes mellitus. Together these two medicines can control your blood sugar levels, lower plasma lipid levels and improve blood pressure. However, the risk of very low blood sugar levels can increase and the dose of these medicines may need to be adjusted.